Integra LifeSciences to Present at the Deutsche Bank Health Care and Bank of America Merrill Lynch Health Care Conferences in May

        Print
| Source: Integra LifeSciences Holdings Corp.

PLAINSBORO, N.J., May 2, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at the following conferences this month:

  • At 4:50 PM ET on Tuesday, May 8, 2012, Mr. Brian Larkin, President, Global Spine & Orthobiologics and Head of Strategic Development of Integra, will present at the Deutsche Bank Health Care Conference in Boston, MA. Mr. Jack Henneman, Chief Financial Officer of Integra, will also be in attendance and available for 1-on-1 meetings. This presentation will not be webcast.
  • At 5:00 PM PT on Tuesday, May 15, 2012, Mr. Henneman will present at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, NV. This presentation will not be webcast.

Integra LifeSciences, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedics, neurosurgery, spine, reconstructive and general surgery. For more information, please visit www.integralife.com

Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2011 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as of the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

Integra LifeSciences Holdings Corporation
John B. Henneman, III
Executive Vice President, Chief Financial Officer
(609) 275-0500


Investor Relations:
Angela Steinway
(609) 936-2268